Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,380,577
-$7,857,582 QoQ
Shares Held
2,881,159
+1.4% QoQ
Ownership
1.93%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. MDXG ranks #154 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,380,577 | 2,881,159 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,238,159 | 2,841,678 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $19,850,715 | 2,843,942 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $17,371,664 | 2,843,153 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $22,135,159 | 2,912,521 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $26,737,913 | 2,779,409 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $16,514,655 | 2,794,358 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $19,058,220 | 2,750,104 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $20,181,438 | 2,620,966 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $22,259,856 | 2,538,182 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,702,627 | 2,428,344 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,409,740 | 2,331,277 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,497,011 | 2,198,537 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,836,990 | 2,099,637 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,895,011 | 2,054,011 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,154,090 | 1,773,513 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,754,110 | 1,646,308 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,184,128 | 1,686,114 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,113,843 | 1,668,951 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $21,854,857 | 1,746,991 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,960,443 | 869,946 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $8,240,653 | 907,561 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||